Publications by authors named "Thomas L Davis"

Claim this Profile
L
Longitudinal Study of Treatment Variability for Parkinson's Disease across Specialized Centers.
Nabila Dahodwala, Theodore Kapogiannis, Amanda Cruz, James C Beck, Thomas L Davis

Mov Disord Clin Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating a motor progression connectivity model across Parkinson's disease stages.
Mallory L Hacker, David A Isaacs, Nanditha Rajamani, Kian Pazira, Eli Abdou, Thomas L Davis

J Neurol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Parkinson's Disease Care through Systematic Screening for Depression.
Connie Marras, Zachary Meyer, Hongliang Liu, Sheng Luo, Sneha Mantri, Thomas L Davis

Mov Disord Clin Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results.
K Ray Chaudhuri, Norbert Kovács, Francesco E Pontieri, Jason Aldred, Paul Bourgeois, Thomas L Davis

J Parkinsons Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connectivity Profile for Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson Disease.
Mallory L Hacker, Nanditha Rajamani, Clemens Neudorfer, Barbara Hollunder, Simon Oxenford, Thomas L Davis

Ann Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease.
Mallory L Hacker, Michael G Tramontana, Kian Pazira, Jacqueline C Meystedt, Maxim Turchan, Thomas L Davis

Parkinsonism Relat Disord· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Differences in Health-Related Quality of Life for Individuals With Parkinson Disease Across Centers of Excellence.
Daniel Garbin Di Luca, Sheng Luo, Hongliang Liu, Melanie Cohn, Thomas L Davis

Neurology· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eleven-Year Outcomes of Deep Brain Stimulation in Early-Stage Parkinson Disease.
Mallory L Hacker, Jacqueline C Meystedt, Maxim Turchan, Kevin R Cannard, Kelly Harper, Thomas L Davis

Neuromodulation· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will Subcutaneous Levodopa Stick? Old Dog, New Trick.
Andrew B Giritharan, Thomas L Davis

Neurology· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease.
Caryl E Sortwell, Mallory L Hacker, David Luke Fischer, Peter E Konrad, Thomas L Davis

Neuromodulation· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel.
Norbert Kovács, Lars Bergmann, Marieta Anca-Herschkovitsch, Esther Cubo, Thomas L Davis

J Parkinsons Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease.
David G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, Paul Bourgeois, Esther Cubo, Thomas L Davis

Mov Disord Clin Pract· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual plaque in a patient with recessive dystrophic epidermolysis bullosa.
Caroline S Zhu, Thomas L Davis, John C Browning

Pediatr Dermatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
David Charles, Mallory L Hacker, Thomas L Davis, Peter E Konrad

Neurology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
Mallory L Hacker, Peter E Konrad, Thomas L Davis, David Charles

Neurology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE.
Jason Aldred, Marieta Anca-Herschkovitsch, Angelo Antonini, Ovidiu Bajenaru, Lars Bergmann, Thomas L Davis

Neurodegener Dis Manag· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomes.
Mallory L Hacker, Maxim Turchan, Lauren E Heusinkveld, Amanda D Currie, Sarah H Millan, Thomas L Davis

Neurology· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States.
Fahd Amjad, Danish Bhatti, Thomas L Davis, Odinachi Oguh, Rajesh Pahwa

Adv Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Tremor on Patients With Early Stage Parkinson's Disease.
Lauren E Heusinkveld, Mallory L Hacker, Maxim Turchan, Thomas L Davis, David Charles

Front Neurol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.
Mallory L Hacker, Mahlon R DeLong, Maxim Turchan, Lauren E Heusinkveld, Jill L Ostrem, Thomas L Davis

Neurology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data.
Miriam R Rafferty, Peter N Schmidt, Sheng T Luo, Kan Li, Connie Marras, Thomas L Davis

J Parkinsons Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating fault lines in Aliso Canyon.
Thomas L Davis

Science· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can lifestyle modification slow progression of Parkinson disease?
Peter Hedera, Thomas L Davis

Neurology· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease.
Mallory L Hacker, Amanda D Currie, Anna L Molinari, Maxim Turchan, Sarah M Millan, Thomas L Davis

J Parkinsons Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study Assessing the Effects of Pallidal Deep Brain Stimulation on Sleep Quality and Polysomnography in Parkinson's Patients.
Christopher M Tolleson, Kanika Bagai, Arthur S Walters, Thomas L Davis

Neuromodulation· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis